「central」の検索結果
14件：11～14件目を表示
-
enju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; Preside...
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509.pdf -
enju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; Preside...
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509_0.pdf -
024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; Preside...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708_0.pdf -
024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; Preside...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708.pdf